Clinical Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Clinical Cancer Research 13, 6032-6039, October 15, 2007. doi: 10.1158/1078-0432.CCR-06-2932
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Holzen, U.
Right arrow Articles by Swisher, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Holzen, U.
Right arrow Articles by Swisher, S. G.

Human Cancer Biology

The Double-Stranded RNA-Activated Protein Kinase Mediates Radiation Resistance in Mouse Embryo Fibroblasts through Nuclear Factor {kappa}B and Akt Activation

Urs von Holzen1,6, Abujiang Pataer2, Uma Raju3, Dora Bocangel2, Stephan A. Vorburger5, Yanna Liu1, Xiaolin Lu2, Jack A. Roth2, Bharat B. Aggarwal4, Glen N. Barber7, Khandan Keyomarsi4, Kelly K. Hunt1 and Stephen G. Swisher2

Authors' Affiliations: Departments of 1 Surgical Oncology, 2 Thoracic and Cardiovascular Surgery, 3 Experimental Radiation Oncology, and 4 Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; 5 Department of Visceral and Transplantation Surgery, Inselspital Bern, Bern, Switzerland; 6 Department of Surgery, University Hospital Basel, Basel, Switzerland; and 7 University of Miami School of Medicine, Miami, Florida

Requests for reprints: Stephen G. Swisher, Unit 445, Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-745-4530; Fax: 713-794-4901; E-mail: sswisher{at}mdanderson.org.

Purpose: Activation of the double-stranded RNA-activated protein kinase (PKR) leads to the induction of various pathways including the down-regulation of translation through phosphorylation of the eukaryotic translation initiation factor 2{alpha} (eIF-2{alpha}). There have been no reports to date about the role of PKR in radiation sensitivity.

Experimental Design: A clonogenic survival assay was used to investigate the sensitivity of PKR mouse embryo fibroblasts (MEF) to radiation therapy. 2-Aminopurine (2-AP), a chemical inhibitor of PKR, was used to inhibit PKR activation. Nuclear factor-{kappa}B (NF-{kappa}B) activation was assessed by electrophoretic mobility shift assay (EMSA). Expression of PKR and downstream targets was examined by Western blot analysis and immunofluorescence.

Results: Ionizing radiation leads to dose- and time-dependent increases in PKR expression and function that contributes to increased cellular radiation resistance as shown by clonogenic survival and terminal nucleotidyl transferase–mediated nick end labeling (TUNEL) apoptosis assays. Specific inhibition of PKR with the chemical inhibitor 2-AP restores radiation sensitivity. Plasmid transfection of the PKR wild-type (wt) gene into PKR–/– MEFs leads to increased radiation resistance. The protective effect of PKR to radiation may be mediated in part through NF-{kappa}B and Akt because both NF-{kappa}B and Akt are activated after ionizing radiation in PKR+/+ but not PKR–/– cells.

Conclusions: We suggest a novel role for PKR as a mediator of radiation resistance modulated in part through the protective effects of NF-{kappa}B and Akt activation. The modification of PKR activity may be a novel strategy in the future to overcome radiation resistance.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.